abstract |
Antigen-binding molecules, chimeric receptors and immune cells engineered for DLL3 are disclosed according to the invention. The invention relates additionally to vectors, compositions and methods of treatment and / or detection using antigen binding molecules for DLL3 and engineered immune cells. |